Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
about
The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.A study on the relationship between clinical features with Ki67 expression and eosinophil cells infiltration in oral squamous cell carcinomaLiver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumorsGenomic landscapes of pancreatic neoplasia.Calculation of the Ki67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies.MicroRNA-10b inhibition reduces E2F1-mediated transcription and miR-15/16 activity in glioblastoma.Pathological and molecular evaluation of pancreatic neoplasms.Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.Neuroendocrine neoplasms of liver - A 5-year retrospective clinico-pathological study applying World Health Organization 2010 classification.Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.Neuroendocrine tumors of the pancreas: current concepts and controversies.The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.Merkel cell carcinoma: mitoses, expression of Ki-67 and bcl-2 correlate with disease progression.WHO Grade 2 Neuroendocrine Tumor in a 15-Year-Old Male: A Case Report and Literature ReviewPathology diagnosis of pancreatic neuroendocrine tumors.Distinctive pathological and clinical features of lung carcinoids with high proliferation index.Cytology assessment can predict survival for patients with metastatic pancreatic neuroendocrine neoplasms.Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors.Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumorsPhosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.Somatostatin Receptor SSTR-2a Expression Is a Stronger Predictor for Survival Than Ki-67 in Pancreatic Neuroendocrine Tumors.The Impact of Phosphohistone-H3-Assisted Mitotic Count and Ki67 Score in the Determination of Tumor Grade and Prediction of Distant Metastasis in Well-Differentiated Pancreatic Neuroendocrine Tumors.Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.Epitope Preservation Methods for Tissue Microarrays: Longitudinal Prospective Study.Can PPH3 be helpful to assess the discordant grade in primary and metastatic enteropancreatic neuroendocrine tumors?Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior.Reliability of Ki-67 Determination in FNA Samples for Grading Pancreatic Neuroendocrine Tumors.[Grading of neuroendocrine tumors].Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary TumorsKi-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 casesPrimary hepatic neuroendocrine neoplasm: Long-time surgical outcome and prognosis
P2860
Q34464857-0F96163E-97ED-4BE4-B87B-69B37C9967C4Q35036723-48AA1B7C-B067-4985-8B7E-3EFD2384FE6CQ35163126-38D10432-A283-4F49-B6C0-D65A4B76E54DQ35170720-F729ED80-A9DD-485A-8DF7-2E7CCE16C458Q35440550-098C4C24-FB6C-481F-BDF8-9476B0ED03ECQ35551867-B03A60A9-BD13-40E0-8645-0FDF2A40C241Q35670143-00257189-428C-4484-B89E-3E49F031C2C7Q37182620-F6B28323-34D5-45D8-BCD7-322CFF35ECE0Q37373285-A87E4739-B530-4A19-968B-E23CB429E7EEQ37631597-4EB21049-3B23-4108-BCE7-75A5E6F06067Q38178882-1C611F85-56D8-435F-8916-9D05EB78A307Q38202029-34570226-64A2-4F73-B41E-12A68DA03354Q38207553-95625CB2-738D-4D03-977F-5743290E47D2Q38236512-E87D6CE7-F850-4FFD-AF27-296BDEFAC859Q38294469-2E8B590C-8E52-4DDE-9986-A61245EB7A25Q38340420-43B43AE9-44E8-4B91-83BC-14F60246A22AQ38718054-0063050D-F31C-4A92-8C26-D67EDF7BD5D1Q38769603-31986ACE-E901-4245-9DFF-E604C0CE0B5FQ38856277-27CA1873-9E26-4432-B0F4-F638B22F6E66Q39022631-8041E9A5-2111-490C-B124-56F314B411ECQ39884529-6FF15BF8-67E1-4D2D-B52D-59D322AB499AQ40288265-99F5D5F0-C179-4B4F-84E2-0D6418A9D761Q40453835-8A65847A-BE36-42DE-94D8-035911360A9CQ40874923-DEACA25B-ECE8-40C6-B788-ADE6F8B00061Q45999443-B74BFCDE-371D-48EA-9234-E66CC4872BF9Q47871784-4CD65921-C212-4ADC-A1B1-1A4D6F268764Q48097270-59FF5245-33A6-4C35-AAE1-66E15955F053Q48120130-A96F6DA9-5446-466C-8356-714AAB0242D0Q48120139-C12053E9-1EC0-4E52-A7C3-C1655D934CD9Q50141023-A9608A18-BA67-44F6-8EC6-06CFDAB04A15Q50863966-A400CF5D-1521-4F68-94D0-5D059B224347Q51317949-16AC9974-4640-429E-A64F-FF536FD0CD54Q51446439-85E30C9F-3779-4812-ACD4-1BF244F1A9F9Q53073082-F3C7B9E8-39B0-4CE8-96AF-7C42E129EBD5Q57793628-9D00561A-8B21-489B-9573-967E143EE334Q57972622-158C2D24-FE4A-4B57-A897-BA158FBEEB92Q58801989-9A771346-C7F1-4B18-882B-48A0ECA9C67C
P2860
Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Grading of well-differentiated ...... rative index and mitotic rate.
@en
Grading of well-differentiated ...... rative index and mitotic rate.
@nl
type
label
Grading of well-differentiated ...... rative index and mitotic rate.
@en
Grading of well-differentiated ...... rative index and mitotic rate.
@nl
prefLabel
Grading of well-differentiated ...... rative index and mitotic rate.
@en
Grading of well-differentiated ...... rative index and mitotic rate.
@nl
P2093
P2860
P50
P1476
Grading of well-differentiated ...... rative index and mitotic rate.
@en
P2093
Barish H Edil
Chanjuan Shi
Christopher L Wolfgang
David S Klimstra
Laura H Tang
Liew Jun Mun
Michael A Choti
Richard D Schulick
Toby C Cornish
Trevor A Ellison
P2860
P304
P356
10.1097/PAS.0000000000000089
P407
P577
2013-11-01T00:00:00Z